The rise and fall of sleeping sickness.
Barrett
Michael P
MP
Division of Infection and Immunity, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK. m.barrett@bio.gla.ac.uk
D000349:Africa / Q000453:epidemiology; D000818:Animals; D004345:Drug Industry / Q000191:economics*; D000518:Eflornithine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D014344:Trypanocidal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014347:Trypanosoma brucei gambiense; D016833:Trypanosoma brucei rhodesiense; D014353:Trypanosomiasis, African / Q000188:drug therapy* / Q000453:epidemiology
D014344:Trypanocidal Agents; D000518:Eflornithine